MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • 2022 International Congress

    Speech markers of Presymptomatic and Prodromal Huntington’s disease

    A. Vogel, C. Chan, G. Stuart, P. Maruff, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To investigate the sensitivity of digital speech measures for detecting subtle cognitive-linguistic and fine motor features in people carrying the expanded HD gene, with…
  • 2022 International Congress

    Motor, epileptic, and developmental phenotypes in genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism

    S. Galosi, L. Pollini, M. Novelli, K. Bernardi, M. Di Rocco, S. Martinelli, V. Leuzzi (Rome, Italy)

    Objective: To provide a detailed clinical characterization of genetic disorders affecting G-protein coupled receptor signaling and cAMP metabolism Background: Genetic disorders affecting G-protein coupled receptor (GPCRs) signaling…
  • 2022 International Congress

    Whole exome sequencing in 62 families with early-onset movement disorders, cerebellar ataxia and hereditary spastic paraplegia from Kazakhstan, Tajikistan, and Azerbaijan

    R. Kaiyrzhanov, M. Ganieva, K. Salayev, U. Guliyeva, S. Gulieva, C. Shashkin, M. Isoqova, N. Asilova, S. Ibrohimov, A. Zeynalova, S. Badalova, I. Hajiyeva, R. Ibadova, N. Zharkinbekova, H. Houlden (Shymkent, Kazakhstan)

    Objective: To report the results of whole-exome sequencing (WES) in 62 families with early-onset movement disorders, cerebellar ataxia, and hereditary spastic paraplegia (HSP) from Kazakhstan,…
  • 2022 International Congress

    Cannabis treatment in patients with Huntington’s disease in a clinic cohort was safe and effective

    N. Omer, A. Bar David, N. Geva, Y. Zlotnik, T. Gurevich, S. Essa (Tel-Aviv, Israel)

    Objective: To estimate the safety and efficacy of Cannabis treatment in HD patients. Background: Huntington's disease (HD) is a neurodegenerative progressive disorder inherited in an…
  • 2022 International Congress

    GNAO1 related disorders: a clinical, genetic, and therapeutic update

    M. Novelli, S. Galosi, G. Zorzi, T. Granata, F. Nardecchia, M. Di Rocco, S. Martinelli, N. Nardocci, V. Leuzzi (Rome, Italy)

    Objective: To review the clinical phenotype and molecular findings of 125 cases with GNAO1-related disorders, delineating the typical phenotype and the phenotypic expansions and tracing…
  • 2022 International Congress

    Molecular diagnosis Approch for Huntington’s Disease in Tunisia

    H. Nehdi, E. Chebbi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: The aim of this study is to establish a molecular diagnosis approach for huntington's Disease (HD) Background: Huntington's disease (HD) is a rare and…
  • 2022 International Congress

    Juvenile Huntington’s Disease in Tunisia: Clinical Diversity and Literature review

    H. Nehdi, E. Chebbi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: We conducted the first JHD clinical and molecular features in Tunisia and North Africa, contributing to better understanding the diverse manifestation of the disease…
  • MDS Virtual Congress 2021

    Normal chorein protein signal on Western blot despite VPS13A mutations in VPS13A disease

    G. Miltenberger-Miltenyi, B. Bader, A. Velayos-Baeza, L. Burghaus, P. Goldsmith, A. Abicht, R. Bhidayasiri, N. Balakrishnan, D. Simon, R. Walker, N. Lubarr, A. Danek (Munich, Germany)

    Objective: Follow up on patients with strong clinical evidence on VPS13A disease, despite normal chorein band expression in Western blot. Background: VPS13A disease is a…
  • MDS Virtual Congress 2021

    Using Human Neural Tissue Methylation to Decipher Epigenetic Characteristics and Cell Type Pathologies in Huntington’s Disease

    A. Glaser, J. Levy, Z. Zhang, L. Salas (Hanover, USA)

    Objective: This study combines methylation data from the two largest EWAS studies in Huntington's Disease (HD) human brain tissue [1,2]. Combined, this study yields the…
  • MDS Virtual Congress 2021

    DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

    I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)

    Objective: The aim of this study was to evaluate the DNA methylation of the CDKN2B/CDKN2B-AS1 enhancer with Huntington's disease and lung cancer. Background: Phenomenon of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley